No Data
HAITONG SEC: The trend of moderate price reductions in the centralized procurement of Traditional Chinese Medicine varieties continues, and the domestic Pharmaceutical industry is expected to usher in a wave of mergers and acquisitions.
HAITONG SEC released a Research Report stating that the gentle trend of price reduction for Traditional Chinese Medicine varieties continues.
Wai Yuen Tong Announces Registrar Change for 2025
WAI YUEN TONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Wai Yuen Tong Medicine Expects Higher Fiscal H1 Profit
Wai Yuen Tong Plans Board Meeting for Key Financial Decisions
Wai Yuen Tong (00897.HK) will hold a board of directors meeting on November 27 to approve the interim performance.
EWai Yuen Tong (00897.HK) announced that the board of directors will hold a meeting on November 27, 2024 (Wednesday) to consider and approve (including) the company and its subsidiaries' interim performance for the six months ended September 30, 2024, as well as consider the distribution of interim dividends (if any).
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
No Data
